Last updated 2026-07-26
Total raised
—
Last: Undisclosed Round 2020-12
Stage
Series F
Founded
2000
Headcount
19
HQ
Caesarea, Israel
Sector
Health Tech & Life Sciences
About
BrainsGate is an Israeli medical device company focused on developing innovative therapies for patients suffering from central nervous system diseases, particularly acute ischemic stroke. Their core technology, the Ischemic Stroke System (ISS), involves electrical stimulation of the sphenopalatine ganglion (SPG) using a miniature implantable neurostimulator to increase cerebral blood flow. The procedure is designed to be quick and minimally invasive, aiming to improve outcomes for stroke patients within a 24-hour window.
Headcount over time
19 employees (2026-09) · 1 point
Offices
Caesarea, Israel · HQ / main office
Q&A
- What is BrainsGate's primary focus?
- BrainsGate is an Israeli medical device company focused on developing innovative therapies for patients suffering from central nervous system diseases, particularly acute ischemic stroke.
- What is BrainsGate's core technology?
- BrainsGate's core technology, the Ischemic Stroke System (ISS), involves electrical stimulation of the sphenopalatine ganglion (SPG) using a miniature implantable neurostimulator to increase cerebral blood flow.
- When was BrainsGate founded?
- BrainsGate was founded in 2000.
- How many employees does BrainsGate currently have?
- BrainsGate has 11-50 employees.
- What was the outcome of the FDA panel for BrainsGate in December 2021?
- In December 2021, low U.S. enrollment contributed to a negative FDA panel outcome for BrainsGate.
- When did BrainsGate raise its most recent funding round and how much was it?
- BrainsGate raised $14,000,000 in an F Round in December 2020.
- Which investors participated in BrainsGate's A Round in August 2005?
- BNP Paribas and Medtronic participated in BrainsGate's A Round in August 2005.
- What was the result of BrainsGate's clinical trial in October 2018?
- In October 2018, BrainsGate narrowly missed its trial endpoint.
Team · 1
Avinoam Dayan
CEO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
Verified
Tags
medical-devicesneuro-stimulationstrokeneurologyminimally-invasivepatientshealthcare-providerstreatmentsmedical-technologies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | brainsgate.com |
|---|---|
| linkedin.com/company/140283 | |
| YouTube | youtube.com/channel/UCuaYZKxRZKbwszkOrEeVmSA |
Identifiers & details
| Founded | 2000 |
|---|---|
| Employees (exact) | 19 |
Radar intelligence
Patents
| EPO | 28 |
|---|
Publications (Crossref)
| Works | 6 |
|---|
Web history (Wayback)
| Domain | brainsgate.com |
|---|
Certificate / subdomain footprint
| Subdomains | 5 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 512988338 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2000-07-30 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 4 — charge (2), violation (1), annual_report (1) |
| Registered address | רותם המדבר 4 קיסריה |
Recent registry events
| Date | Event |
|---|---|
| 2026-05-31 | סילוק שעבוד |
| 2026-06-30 | עדכון הפרה |
| 2026-06-30 | דו~ח שנתי-שינוי בהוראות בתקנון |
| 2026-06-08 | רישום שעבוד |